NCT03869814View on ClinicalTrials.gov

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

UnknownOBSERVATIONAL

Enrollment

6,500

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

June 13, 2023

Study Completion Date

September 13, 2023

Conditions

Diagnosis of Cancer of Various Organs

Interventions

OTHER

Blood Draw

Blood Draw

Trial Locations (1)

92121

RECRUITING

Bluestar Genomics, Inc., San Diego

Sponsors

Lead Sponsor

ClearNote Health

All Listed Sponsors

lead

ClearNote Health

INDUSTRY

NCT03869814 - Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types | Biotech Hunter | Biotech Hunter